Hemogenyx Pharmaceuticals (HEMO)

Sector:

Pharma and Biotech

1.32p
   
  • Change Today:
      0.005p
  • 52 Week High: 3.96p
  • 52 Week Low: 1.28p
  • Currency: UK Pounds
  • Shares Issued: 1,341.82m
  • Volume: 77,749
  • Market Cap: £17.64m
  • RiskGrade: 340

Regulatory News

Second Price Monitoring Extn 18-Nov-2022 11:05 RNS
Price Monitoring Extension 18-Nov-2022 11:00 RNS
Second Price Monitoring Extn 27-Oct-2022 16:40 RNS
Price Monitoring Extension 27-Oct-2022 16:35 RNS
Second Price Monitoring Extn 27-Oct-2022 14:05 RNS
Price Monitoring Extension 27-Oct-2022 14:00 RNS
Half-year Report 29-Sep-2022 08:00 RNS
Presentation at H.C. Wainwright Global Conference 01-Sep-2022 08:45 RNS
Appointment of Director of Quality 22-Aug-2022 07:00 RNS
Approval and Issuance of Antibody Patent 15-Aug-2022 07:00 RNS
Appointment of Medical Director 10-Aug-2022 07:00 RNS
Second Price Monitoring Extn 09-Aug-2022 14:06 RNS
Price Monitoring Extension 09-Aug-2022 14:00 RNS
New Custom R&D Facility Opening 13-Jul-2022 07:00 RNS
Investor Webinar Recording 08-Jul-2022 12:25 RNS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HEMO Market Data

Currency UK Pounds
Share Price 1.32p
Change Today 0.005p
% Change -0.38 %
52 Week High 3.96p
52 Week Low 1.28p
Volume 77,749
Shares Issued 1,341.82m
Market Cap £17.64m
RiskGrade 340

HEMO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
50.72% below the market average50.72% below the market average50.72% below the market average50.72% below the market average50.72% below the market average
68.63% below the sector average68.63% below the sector average68.63% below the sector average68.63% below the sector average68.63% below the sector average
Price Trend
45.02% below the market average45.02% below the market average45.02% below the market average45.02% below the market average45.02% below the market average
1.89% below the sector average1.89% below the sector average1.89% below the sector average1.89% below the sector average1.89% below the sector average
Income Not Available
Growth Not Available

HEMO Dividends

No dividends found

Trades for 26-Jun-2024

Time Volume / Share Price
08:15 77,598 @ 1.29p
08:03 151 @ 1.28p

HEMO Key Personnel

CEO Vladislav Sandler Ph.D.

Top of Page